E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers O > Headlines for OncoMed Pharmaceuticals, Inc. > News item
Published on 8/17/2016 in the Prospect News PIPE Daily.

OncoMed Pharmaceuticals plans to conduct public sale of common stock

Leerink Partners is bookrunner; deal funds general corporate purposes

By Devika Patel

Knoxville, Tenn., Aug. 17 – OncoMed Pharmaceuticals, Inc. will price a public offering of common stock with a 30-day greenshoe, according to a prospectus supplement filed Wednesday with the Securities and Exchange Commission.

Leerink Partners is the bookrunner.

Proceeds will be used for general corporate purposes.

The biopharmaceutical company is based in Redwood City, Calif.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.